DrRebecca Shipley

Rebecca directs and co-ordinates experimental research studies investigating disease mechanisms pertaining to chronic obstructive pulmonary disease (COPD), primarily focusing on manipulating the gut-lung axis to treat COPD. Rebecca's role aims to identify novel therapeutics and preventative treatments for COPD and other chronic lung diseases.

Historically, Rebecca completed her PhD in the field of virology, aiming to define the antigenic requirements for pan-lyssavirus neutralisation. Post-PhD, Rebecca researched detection, infection, and transmission of SARS-CoV-2 variants.